Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
- Comparing Advanced Modality Needs, Part 1: Manufacturing
- What Will It Take To Turn CGT Innovation Into Market Success?
- Why CMC Must Shape Critical Decisions Early In Development
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- Closing The Gap Between Modeling And GMP Predictive Control
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Accelerating Clinical Data Review With Traceable Workflows
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Perfusion Cell Line Development For Intensified Processes
The biopharmaceutical industry is transforming by shifting to continuous and intensified upstream bioprocesses, which are driven by evolving demands. Discover the key goals and innovations shaping this transition for modern healthcare.
-
Confirming Structural Consistency With HDX-MS
To support regulatory confidence, a biopharma company evaluated whether manufacturing changes affected its monoclonal antibody's higher-order structure.
-
Automation Of 3D Intestinal Organoids Culture
Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
-
Multi-Column Chromatography For Efficient Polishing Purification
Boost downstream efficiency with multi-column chromatography for polishing to achieve higher productivity, reduced resin costs, and automated operation while maintaining purity and recovery.
-
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
-
Mild pH Protein A Purification Step With A Mild Elution Resin
As antibody formats diversify, low-pH protein A elution can drive aggregation and yield loss. Learn how milder elution conditions during capture can help protect sensitive molecules and ease challenges.
-
Where Speed Meets Complexity In Bioprocess Development
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
-
How Remote Pharmacy Monitoring Improves Trial Compliance
Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.
-
Improved Methods For CRISPR-Cas9 Homology-Directed Repair
Precise genome editing depends on improving HDR efficiency. Learn how guide selection, template design, homology arm optimization, and delivery strategies work together to drive higher-fidelity edits.
NEWSLETTER ARCHIVE
- 11.18.26 -- OPCU: Strengthening Cell And Gene Therapy Programs With Robust Analytics
- 11.18.26 -- What Will It Take To Turn CGT Innovation Into Market Success?
- 11.17.26 -- What If The Body Could Make Its Own Medicine?
- 11.17.26 -- Reducing Tech Transfer Risk In Autologous CAR T Automation
- 11.17.26 -- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- What Will It Take To Turn CGT Innovation Into Market Success?
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

